Centro De Ingenieria Genetica Y Biotecnologia

Centro De Ingenieria Genetica Y Biotechnologia

Centro De Inmunologia Molecular

Luis Enrique Fernández Molina

Boris Ernesto Acevedo Castro

Jorge Victor Gavilondo Cowley

Omar Lopez Ocejo

Ricardo De La Caridad Silva Rodriguez

Alexis Musachio Lasa

Ernesto Galban Rodriguez

Mónica Bequet Romero

Dania Marcia Vásquez Blomquist

Dania Marcia Vázquez Blomquist

Greta Garrido Hidalgo

Alejandro López Requena

Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis. These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others.

Active antiangiogenic therapy

Growing community of inventors

Ciudad de la Habana, Cuba

Luis Enrique Fernández Molina